LMO7-AS1

Across TCGA pan-cancer cohorts, LMO7-AS1 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated LMO7-AS1 data layer compared with 23 for mass-spec protein.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher LMO7-AS1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated LMO7-AS1 expression acts as an unfavorable survival marker.

STAD and KIRP are the cancer types where LMO7-AS1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Median	All	0.075	0.688	<.001	42	view →
KIRP	DFS	Median	All	0.133	0.605	.014	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

LMO7-AS1–STAD (OS)

Open the STAD breakdown →